Physician profile
Brian C Kelley
NPI 1750587838
$192,643.96
in general payments reported to CMS, 2019-2025
11 companies · $21K in 2025
The $21K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $669 · 2020: $16K · 2021: $45K · 2022: $31K · 2023: $42K · 2024: $38K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $98K · Food and Beverage: $1,756 · Travel and Lodging: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $98,280.57 |
| Food and Beverage | $1,755.98 |
| Travel and Lodging | $757.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $190,375.04 | 2019-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Boston Scientific Corporation | $1,179.75 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Sanara Medtech INC. | $347.89 | 2021-2022 | |
| Medtronic USA, INC. | $214.26 | 2019 | |
| Nevro Corp. | $177.89 | 2022 | |
| Medtronic, INC. | $140.15 | 2022-2023 | Intellis Adaptivestim |
| Aesculap, INC. | $80.00 | 2019 | |
| Stryker Corporation | $56.24 | 2023 | Ivas, Universal Neuro 3 |
| Ethicon US, LLC | $38.12 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.56 | 2025 | |
| Vertiflex, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.